Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eicosanoids: role in experimental renal disease.

S Klahr1, M L Purkerson

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Advances in Experimental Medicine and Biology
|January 1, 1989
PubMed
Summary

Vasoactive prostaglandins and thromboxane A2 influence renal hemodynamics in experimental kidney disease. Further research is needed to fully understand eicosanoid roles in renal disease pathogenesis and pathophysiology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression of chronic renal disease.

Heart disease (Hagerstown, Md.)·2002
Same author

The role of nitric oxide in hypertension and renal disease progression.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
Same author

Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.

American journal of physiology. Renal physiology·2001
Same author

Urinary tract obstruction.

Seminars in nephrology·2001
Same author

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

American journal of physiology. Renal physiology·2000
Same author

The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease.

Kidney international. Supplement·2000

Area of Science:

  • Nephrology
  • Renal Physiology
  • Immunology

Background:

  • Vasoactive prostaglandins and thromboxane A2 are implicated in modulating hemodynamic changes in experimental renal disease models.
  • Prostaglandins like PGE2 and PGI2 may maintain renal blood flow and GFR during impaired perfusion.
  • Thromboxane A2 is a suspected vasoconstrictor reducing renal blood flow and GFR in certain experimental renal disease models.

Purpose of the Study:

  • To explore the role of vasoactive eicosanoids in the pathophysiology of experimental renal disease.
  • To investigate the involvement of prostaglandins and thromboxane A2 in renal hemodynamic alterations.
  • To understand the contribution of eicosanoids to immunological events in renal disease.

Main Methods:

  • Review of existing literature on eicosanoid function in experimental renal disease models.
  • Analysis of studies investigating prostaglandin and thromboxane A2 synthesis and effects.
  • Examination of research on arachidonic acid metabolites in renal pathophysiology.

Main Results:

  • Evidence suggests prostaglandins (PGE2, PGI2) act as vasodilators supporting renal function under stress.
  • Thromboxane A2 is identified as a vasoconstrictor contributing to reduced renal blood flow and GFR.
  • Eicosanoids and arachidonic acid metabolites may influence immunological aspects of renal disease onset and progression.

Conclusions:

  • The precise pathophysiologic role of eicosanoids in experimental renal disease remains incompletely understood.
  • Further studies are required to elucidate the multifaceted roles of eicosanoids in renal disease.
  • Understanding eicosanoid effects on hemodynamics, immunology, and mesangial cell function is crucial for comprehending renal disease pathogenesis.

Related Experiment Videos